Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × Vinorelbine × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 9 Neoplasm Metastasis 6 Hodgkin Disease 6 Neoplasms 4 Recurrence 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Mesothelioma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Carcinoma 2 Breast Neoplasms, Male 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Pleural Effusion, Malignant 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non - Small Cell Lung Cancer NSCLC 1 Neuroendocrine Tumors 1 Neuralgia 1 Metatropic dwarfism 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Locally Advanced Non-Small Cell Lung Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Desmoplastic Small Round Cell Tumor 1

Interventions

Sunitinib 56 Nivolumab 37 Everolimus 29 Bevacizumab 29 pembrolizumab 24 Sorafenib 23 pazopanib 22 Axitinib 21 aldesleukin 13 Ipilimumab 13 cabozantinib 12 temsirolimus 11 Interferon alpha-2 10 Cyclophosphamide 10 Interleukin-2 9 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 lenvatinib 5 fludarabine phosphate 5 avelumab 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 atezolizumab 4 Nephrectomy 4 Interferon-alpha 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡